Octagon Capital Advisors LP 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-08-28 4:02 pm Sale | 2024-08-26 | 13G | AN2 Therapeutics, Inc. ANTX | Octagon Capital Advisors LP | 0 0.000% | -3,009,927![]() (Position Closed) | Filing |
2024-07-03 08:02 am Purchase | 2024-06-13 | 13G | AN2 Therapeutics, Inc. ANTX | Octagon Capital Advisors LP | 3,009,927 10.100% | 3,009,927![]() (New Position) | Filing |